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Abstract
Background: Epidemiological and experimental studies have extensively indicated that chronic subclinical systemic
inflammation (CSSI) and oxidative stress are risk factors for several chronic diseases, including cancer, arthritis, type 2
diabetes, and cardiovascular and neurodegenerative diseases. This study examined the protective effect of stingless
bee honey (SBH) supplementation against lipopolysaccharide (LPS)-induced CSSI, pointing to the possible
involvement of NF-κB, p38 MAPK and Nrf2 signaling.
Methods: CSSI was induced in male Sprague Dawley rats by intraperitoneal injection of LPS three times per week
for 28 days, and SBH (4.6 and 9.3 g/kg/day) was supplemented for 30 days.
Results: LPS-induced rats showed significant leukocytosis, and elevated serum levels of CRP, TNF-α, IL-1β, IL-6, IL-8,
MCP-1, malondialdehyde (MDA) and 8-hydroxy-2′-deoxyguanosine (8-OHdG), accompanied with diminished
antioxidants. Treatment with SBH significantly ameliorated inflammatory markers, MDA and 8-OHdG, and enhanced
antioxidants in LPS-induced rats. In addition, SBH decreased NF-κB p65 and p38 MAPK, and increased Nrf2 expression in
the liver, kidney, heart and lung of LPS-induced rats. Furthermore, SBH prevented LPS-induced histological and functional
alterations in the liver, kidney, heart and lung of rats.
Conclusion: SBH has a substantial protective role against LPS-induced CSSI in rats mediated via amelioration of
inflammation, oxidative stress and NF-κB, p38 MAPK and Nrf2 signaling.
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Background
Inflammation is defined as a biological protective response
to counteract stressor and harmful pathogenic stimuli [1].
The inflammatory process, which could be clinical or sub-
clinical, consists of a tremendously complex interplay of
immune cells, blood vessels and molecular mediators [2].
The clinical features of inflammation have been
traditionally identified as cardinal signs, including redness,
swelling, pain and loss of function [3]. However, dysregu-
lation of inflammatory suppression occurs in autoinflam-
matory diseases due to pointless events of inflammation
[4]. The presence of inflammation is inferred if nuclear
factor-kappaB (NF-κB) is activated and pro-inflammatory
cytokines production is increased [5]. Hence, various
pathological conditions are associated with increased
levels of the inflammatory mediators despite the absence
of clinical signs. These conditions have been characterized
in different terms namely, chronic subclinical systemic in-
flammation (CSSI), low-grade chronic inflammation,
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mini-inflammation and meta-inflammation (metabolical-
ly-triggered inflammation) [6]. The exposure of cells to
oxidative stress and metabolic malfunction triggers CSSI
which plays an important role to restore homeostasis [7].
Oxidative stress and inflammation have been found to
have a positive feedback mechanism that arises at systemic
or local level [1]. Hence, the crosstalk between CSSI and
oxidative stress has been thought to be involved in the
pathogenesis of type 2 diabetes, cancer, metabolic syn-
drome, obesity, arthritis, osteopenia, and neurodegenera-
tive and cardiovascular diseases [8–14].
The initial step of activated CSSI is the release of
pro-inflammatory cytokines and mediators. The elevated
levels of C-reactive protein (CRP), interleukin (IL)-6 and
tumor necrosis factor (TNF)-α have been used clinically
to determine the presence of CSSI [15]. TNF-α and
IL-1β have shown a perpetuation of signaling cascade,
while monocyte chemoattractant protein (MCP)-1 func-
tions as a chemoattractant molecule for leukocytes,
recruiting neutrophils and monocytes to the site of dam-
age and inflammation [16]. At the same time, activation
of NF-κB is concomitant with increased production of
reactive oxygen species (ROS) which ultimately lead to
oxidative damage of the cellular components, protein,
lipids and DNA. Despite the presence of efficient
anti-inflammatory drugs, such as, corticosteroids and
non-steroidal anti-inflammatory drugs (NSAIDs), their
long-term administration has been associated with
numerous side effects [17]. Therefore, new
anti-inflammatory agents with fewer or no side effects
are needed.
Healthy functional foods rich in bioactive com-
pounds have been linked with lower CSSI [18], and
a strong evidence of epidemiological studies has in-
dicated that the consumption of polyphenol-rich
foods may modulate CSSI [19]. Since floral nectar is
rich in polyphenols, honey may be considered as a
functional transporter of medicinal plants’ polyphe-
nols [20]. In this context, stingless bee honey (SBH)
has been found to be rich in polyphenols when com-
pared with other types of honey [21–23]. Recently,
emerging experiments have indicated that SBH pos-
sesses several beneficial effects under pathological
conditions, rendering it a promising functional food
with anti-oxidant, anti-bacterial, anti-cancer and
anti-inflammatory properties [24–28]. Therefore,
SBH could be a reasonable dietary intervention to
prevent or treat CSSI-related diseases. The current
study aimed to investigate the ameliorative potential
of SBH in lipopolysaccharide (LPS)-induced CSSI
with an emphasis on oxidative stress, and NF-κB,
p38 mitogen-activated protein kinase (MAPK) and
nuclear factor erythroid 2–related factor 2 (Nrf2)
signaling in rats.
Methods
Reagents and kits
LPS (derived from Escherichia coli 055:B5) and all solvents
and reagents were supplied by Sigma-Aldrich (St. Louis,
MO, USA). CRP, reduced glutathione (GSH),
glutathione-S-transferase (GST), glutathione peroxidase
(GPx), malondialdehyde (MDA) and 8-hydroxy-2′-deoxy-
guanosine (8-OHdG) assay kits were purchased from Melsin
Medical Co. (Changchun, Jilin, China). IL-6, IL-8, TNF-α,
IL-1β, MCP-1, NF-κB p65, p38 MAPK and Nrf2 sandwich
ELISA kits were supplied by Wuhan Fine Biotech (Wuhan,
China).
SHB sample and LC-MS/MS analysis
SBH, produced by Trigona, was supplied by local honey
accumulator in Johor Bahru state, Malaysia. The botan-
ical origin of SBH was based on different types of flora,
including Forest Mangorve (Acacia mangium), Rambu-
tan (Nephelium lappaceum), Longan (Dimocarpus lon-
gan) and Belimbing (Averrhoa carambola). SBH was
kept in sterile air-tight-glass bottles at 15 °C to prevent
any moisture absorption during the collection and ex-
perimental time.
Each peak of SBH separated using LC-ESI-MS/MS
was carried out using AB Sciex 5500Q Trap LC/MS-MS
system consisting of degasser, binary pump, auto sam-
pler and column heater. The column vent was coupled
to an Agilent 1290 series UHPLC mass spectrometer
(Agilent Technologies, Palo Alto, CA, USA), equipped
with an ESI ion source. Data acquisition and mass spec-
trometric evaluation were performed in the laboratory
computer of our institute using Sciex Analyst software
(version 1.5). For chromatographic separation, a reversed
phase C18 column (Phenomenex Synergi Fusion; 100
mm X 2.1 mm, particle size 3 μm) was used with work-
ing temperature 35 °C (Waters, MA, USA). The injection
volume was 10 μL. The mobile phase solvents contained
solvent A (water with 0.1% formic acid and 5mM am-
monium formate) and solvent B (acetonitrile with 0.1%
formic acid and 5mM ammonium formate). The follow-
ing gradient run program was applied: 5–95% B: 0.01–
10.0 min, holding for 2 min and back to 10% B in 0.1
min and re-equilibration for 3 min. The overall flow rate
was 250 μl/min. The following operating conditions were
used during all MS experiments: for (ESI) Turbo inter-
face operating was in a negative mode that has been
proven to be more selective and efficient in characteriz-
ing phenolic compounds [29], the capillary voltage was
set to 4.5 kV, the drying temperature to 500 °C, the
nebulizer pressure to 40 psi and the drying gas flow to
100/min. The single ion monitoring (SIM) modality was
performed to quantify the molecular ions of phenolic
compounds. The SIM analysis, in this experiment, was
scanned in the range of 100–1000m/z for full scan and
Ranneh et al. Nutrition & Metabolism           (2019) 16:15 Page 2 of 17
50–1000m/z for MS/MS scan. The mass fragmentation
was done based on ACD/Labs advanced chemometrics
mass fragmentation predictive software.
The phenolic acids and flavonoids were identified
using a combination of liquid chromatography with
mass spectrometry (ESI-LC-MS/MS) based on their
ultraviolet (UV) spectra, retention time, mass spectra
and by comparing with our standard library information
that includes 500 established phenolic compounds.
Calculation of SHB dose for the in vivo experiments
Consuming honey for two weeks continuously at a dose
of 1.2 g/kg in healthy subjects has shown an improve-
ment in the antioxidant status [30]. In addition, a clinical
trial has proven that the consumption of a diet supple-
mented with 1.5 g/kg increased the level of antioxidants
[31]. Nonetheless, there are various in vivo experiments
that designed the dosage of honey treatment based on
isometric scaling (direct extrapolation on g/kg basis).
Tualang and Gelam honeys were administrated orally to
rodents at doses range from 1 to 2 g/kg/day which was
used previously in clinical trials [32, 33]. In the current
investigation, we calculated the dose of SBH according
to the Food and Drug Administration (FDA) guidelines.
Based on previous clinical trial [31], the consumed
honey at a dose of 1.5 g/kg was converted mathematic-
ally into the animal equivalent dose using allometric
scaling. The animal equivalent doses of biological com-
pounds were calculated using the following formula:
AED
mg
kg
 
¼ HED mg
kg
 
x Km ratio
AED: Animal Equivalent Dose, HED: Human Equiva-
lent Dose and Km ratio is a correction factor estimated
by dividing the average body weight (kg) of species to its
body surface area (m2). Thus, rats correction factor is
equal to 6.2 [34]. These guidelines are the most accept-
able for human to animal dose conversion for biological
active agents [35]. Based on this equation, the AED is
9.3 g/kg.
Experimental animals and treatments
Animal ethics approval was obtained from the Institu-
tional Animal Care and Use Committee (IACUC) of
University Putra Malaysia prior to starting the study
(UPM/IACUC/AUP-R007/2017). A total of 36
pathogen-free 7-weeks old male Sprague-Dawley (SD)
rats, weighing 250–290 g, were obtained from University
Putra Malaysia and used in the present study. The rats
were housed in cages under standard conditions with 12
h–12 h light-dark cycle, and normal temperature (22–24
°C) and humidity (40–60%). The rats were given free ac-
cess to a standard rodent chow and water ad libtium
and were acclimatized for two weeks before starting the
experiment.
The rats were divided randomly into six groups (n = 6)
as following (Fig. 1):
Group 1 (Control): rats received distilled water via oral
gavage for 30 days and intraperitoneal (ip) injection of
physiological saline 3 times/week for 28 days.
Group 2 (4.6 g/kg SBH): rats received 4.6 g/kg SBH
dissolved in distilled water via oral gavage for 30 days
and ip injection of physiological saline 3 times/week for
28 days.
Group 3 (9.3 g/kg SBH): rats received 9.3 g/kg SBH
dissolved in distilled water via oral gavage for 30 days
and ip injection of physiological saline 3 times/week for
28 days.
Group 4 (LPS): rats received distilled water via oral
gavage for 30 days and ip injection of LPS (1 mg/kg) dis-
solved in physiological saline 3 times/week for 28 days.
Group 5 (LPS + 4.6 g/kg SBH): rats received 4.6 g/kg
SBH dissolved in distilled water via oral gavage for 30
days and ip injection of LPS (1 mg/kg) dissolved in
physiological saline 3 times/week for 28 days.
Group 6 (LPS + 9.3 g/kg SBH): rats received 9.3 g/kg
SBH dissolved in distilled water via oral gavage for 30
days and ip injection of LPS (1 mg/kg) dissolved in
physiological saline 3 times/week for 28 days.
Measurement of body weight, food intake and survival
rate
Body weight and food intake were measured each five
days for each animal using electric digital scale.
Pre-weighed foods were given to the rats on the first day
of experiment, then food intake was measured daily by
subtracting the weight of food bin from the previous
day. The survival percentage of the animals was carried
on through a close observation and follow-up.
Kaplan-Meier survival curve was used to analyze the es-
timated probability.
Termination procedure and hematological measurements
After 30 days of the experiment, the animals were anes-
thetized using ip injection of sodium pentobarbital (70
mg/kg) and were sacrificed by withdrawing the blood via
cardiac puncture. Half of the blood was collected on
EDTA to measure the white blood cells (WBCs) count
using an automated blood cell analyzer (Abbott Cell
Dyn 1800, Abbott, Illinois, USA), while the other half
was used to separate serum. The rats were dissected im-
mediately, and liver, kidney, heart and lung were surgi-
cally excised and washed with ice-cold phosphate
buffered saline (PBS). Samples from each tissue were
collected on 10% neutral buffered formalin while others
were minced and homogenized (10% w/v) in ice-cold 50
mM sodium dihydrogen phosphate buffer (pH = 7.5)
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containing 1 mM EDTA and 1% Triton-X. The homoge-
nates were centrifugated at 10,000 g for 20 min at 4 °C,
and supernatants were collected and stored at − 80 °C.
The protein content in the tissue homogenates was esti-
mated according to the method of Lowry et al. [36]. The
homogenates were kept frozen at − 80 °C for further
analysis.
Determination of inflammatory mediators
Serum levels of CRP, IL-1β, IL-6, IL-8, TNF-α and
MCP-1 were determined using specific ELISA kits ac-
cording to the manufacturer’s instructions.
Determination of NF-κB p65, p38 MAPK, and Nrf2
NF-κB p65, p38 MAPK and Nrf2 were determined in
the homogenate samples of liver, kidney, heart and lung
using specific ELISA kits according to manufacturer’s
instructions.
Determination of antioxidants and oxidative stress
markers
GSH, GST, GPx, 8-OHdG and MDA were determined in
serum samples using commercially available specific
assay kits.
Determination of liver, kidney and heart function markers
Alkaline phosphatase (ALP), aspartate aminotransferase
(ALT), alanine aminotransferase (AST), creatinine, urea
and creatine kinase (CK) were determined in the serum
samples using Hitachi 900 Auto Analyzer (Roche
Diagnostics, Switzerland), according to the manufac-
turer’s protocol.
Histological examination
The fixed samples from liver, kidney, heart and lung
were embedded in paraffin blocks to process for routine
histological evaluation using hematoxylin and eosin
(H&E) staining [37]. A skilled pathologist who was blind
to the study evaluated the pathological changes and
scored inflammation using Microscope Imaging Cell
Software connected with Olympus light microscope
BX40 (Olympus Optical Co., Japan). Inflammation scor-
ing was conducted based on the following criteria: score
0 = normal tissue (absence of inflammation), score 1 =
the inflammatory cells and tissue damage are present in
less than 25% of field view, score 2 = inflammation and
tissue damage involved in 25 to 50% of field view, score
3 = inflammation and tissue damage involved in 50 to
75% of field view, and score 4 = inflammation and tissue
damage involved in more than 75% of field view.
Statistical analysis
Quantitative results were expressed as mean ± standard
error of the mean (SEM). The analysis of data was per-
formed using GraphPad Prism software (Prism 7.0,
GraphPad Software Inc., CA, USA). The normality of
data (Kolmogorove-Smirnov test) and homogeneity of
variance were performed. The significance level was
tested using one-way analysis of variance (ANOVA)
followed by a post hoc Tukey’s test. A P value less than
0.05 was considered significant.
Fig. 1 A schematic diagram showing the experimental design. SBH, Stingless bee honey; LPS, Lipopolysaccharide
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Results
Identification of polyphenols in SBH by LC- ESI-MS/MS
Based on the optimization conditions of LC-ESI-MS/MS,
SBH was subjected to identify the polyphenols. By search-
ing in our standard library information (e.g. Peak retention
times, UV spectrum, [M-H] (m2) and ESI-MS/MS data), a
total of 18 phenolic compounds, consisting of around 8
phenolic acid compounds and 5 flavonoids, were investi-
gated with range of 0.8–12.4 retention times (RT) in total
ion chromatogram (Table 1 and Fig. 2). Peaks 1, 2, 3, 4,
10, 12, 14, and 18 referred to phenolic acid class while
peaks 5, 7, 8, 13 and 16 belong to the flavonoids class. The
other 5 unknown compounds were not identified under
the same conditions. As shown in Fig. 2 and Table 1, gallic
acid, caffeic acid, chrysin, cinnamic acid,
2-hydroxycinnamic acid, kaempferol, p-coumaric acid,
catechin, quercetin-3-O-rutinosid, caffeic acid phenethyl
ester and 4-hydroxybenzoic acid were identified in SBH.
Notably, caffeic acid, caffeic acid phenethyl ester, cinnamic
acid, 2-hydroxycinnamic acid, and p-coumaric acid are
classified as hydroxycinnamic acids.
Effect of SBH on body weight, food intake and survival
rate in LPS-induced rats
Oral supplementation of SBH didn’t induce significant
changes in the body weight of normal rats as repre-
sented in Fig. 3A. LPS-induced rats showed a significant
(P < 0.05) reduction in body weight during the first week,
but after 10 days of the experiment this reduction wasn’t
significant when compared with the control group. On
the other hand, LPS-induced rats treated with SBH ex-
hibited non-significant changes in body weight (Fig. 3A).
Moreover, a notable decrease in food consumption with
18 g was observed in the LPS group, corresponding with
the same day of weight reduction, but this reduction was
recovered to reach 30 g on day 10, as shown in Fig. 3B.
The rats in LPS + 4.6 g/kg SBH group exhibited less food
intake when compared with the control group; however,
this reduction was not significant (Fig. 3B).
The survival curves of all animal groups during 30
days of the experiment are demonstrated in Fig. 3C. The
survival rate was 100% in the control and
SBH-supplemented, and LPS-induced rats treated with
9.3 g/kg SHB groups. In contrast, the survival rate of
LPS-induced rats supplemented with 4.6 g/kg SBH
(83.4%) was significantly less than the control group.
Two rats from LPS group were died at different inter-
vals, showing a significant (P < 0.05) reduction in sur-
vival rate (66.7%). The difference in survival rate
between untreated and 9.3 g/kg SBH treated
LPS-induced was significant (P < 0.05).
Effect of SBH on hematological changes in LPS-induced
rats
The total number of WBCs in LPS-induced rats was sig-
nificantly higher than that of the normal group as
depicted in Fig. 4A. Similarly, neutrophils (Fig. 4B), lym-
phocytes (Fig. 4C), monocytes (Fig. 4D) and neutrophils/
Table 1 Phenolic compounds identified in SBH by LC-MS/MS with ESI
Peak No RT (min) [M-H]− (Frag. MS2 m/z) Molecular formula Compounds
1 0.92 169 (125) C7H6O5 Gallic acid
2 1.3 179 (135) C9H8O4 Caffeic acid
3 1.74 283.8 (241, 221, 179) C17H16O4 Caffeic acid phenethyl ester
4 2.09 197 (182, 147) C9H10O5 Syringic acid
5 2.75 289 (244.9, 175, 147) C15H14O6 Catechin
6 2.97 775 (715) NI Unknown
7 3.87 269 (251, 225, 205) C15H10O5 Apigenin
8 4.2 253 (209, 193, 178) C15H10O4 Chrysin
9 4.77 221 NA Unknown
10 5.3 147 (118, 129, 102) C9H8O2 Cinnamic acid
11 5.67 162 NI Unknown
12 6.5 165 (147, 119) C9H8O3 2-Hydroxycinnamic acid
13 7.6 285 (175, 151, 133) C15H10O6 Kaempferol
14 8.5 163 (119) C9H8O3 P coumaric acid
15 8.9 959 (913) NI Unknown
16 9.6 609 (301) C9H8O3 quercetin-3-O-rutinosid
17 10.2 614 (478, 452, 342) NI Unknown
18 12.4 137 (93) C7H6O3 4-Hydroxybenzoic acid
NI, Not identified; RT, Retention time; [M-H]−, Molecular mass of honey extract on the loss of one proton measured by SIM
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lymphocytes ratio (Fig. 4E) were significantly increased
in LPS group when compared with the control group.
Treatment with either dose of SBH significantly amelio-
rated both the total and differential WBCs count in
LPS-induced rats (Fig. 4). Normal rats received either
dose of SBH didn’t demonstrate any notable changes in
WBCs when compared with the control group (Fig. 4).
Effect of SBH on inflammatory cytokines and mediators in
LPS-induced rats
Serum levels of CRP (Fig. 5A), TNF-α (Fig. 5B), IL-1β
(Fig. 5C), IL-6 (Fig. 5D), IL-8 (Fig. 5E) and MCP-1 (Fig.
5F) were significantly (P < 0.05) increased in
LPS-induced rats when compared with the control
group. LPS-induced rats treated with both doses of SBH
exhibited significantly ameliorated serum levels of CRP,
TNF-α, IL-1β, IL-6 and IL-8. However, the daily supple-
mentation of 4.6 g/kg SBH didn’t reduce the levels of
MCP-1, whereas the higher dose (9.3 g/kg) significantly
(P < 0.05) decreased serum MCP-1 in LPS-induced rats
(Fig. 5F). Oral administration of 4.6 and 9.3 g/kg SBH
didn’t induce significant changes in serum inflammatory
mediators in normal rats (Fig. 5).
Effect of SBH on NF-κB p65 and p38 MAPK in LPS-
induced rats
NF-κB p65 (Fig. 6A) and p38 MAPK (Fig. 6B) were
assayed in the tissue homogenate of liver, kidney, heart
and lung of rats. The results showed significant (P <
0.05) increase in both NF-κB p65 (Fig. 6A) and p38
MAPK (Fig. 6B) levels in all targeted organs of
LPS-induced rats when compared with the control
group. Treatment of the LPS-induced rats with SBH re-
markably decreased the levels of NF-κB p65 and p38
MAPK levels. However, the effect of 4.6 g/kg SBH on
liver NF-κB p65 and heart p38 MAPK levels was
non-significant when compared with the LPS control
group.
Both doses of SBH didn’t exert a significant effect on
the levels of NF-κB p65 and p38 MAPK in liver, kidney,
heart and lung of normal rats (Fig. 6).
Effect of SBH on oxidative stress markers and
antioxidants in LPS-induced rats
The involvement of antioxidant efficacy of SBH in at-
tenuating CSSI was determined through quantifying the
antioxidant enzymes and oxidative stress markers in
LPS-induced rats. As presented in Fig. 7, a remarkable
increase in MDA and 8-OHdG along with a significant
decrease in GSH, GST and GPx were observed in LPS
group when compared with the control group. On the
other hand, daily supplementation of SBH significantly
ameliorated MDA (Fig. 7A), 8-OHdG (Fig. 7B), GSH
(Fig. 7C), GPx (Fig. 7D) and GST (Fig. 7E) in
LPS-induced rats, whereas exerted no effect in normal
rats.
Effect of SBH on Nrf2 in liver, kidney, heart and lung of
control and LPS-induced rats
Nrf2 is a redox-sensitive transcription factor that control
the expression of several antioxidant and defense pro-
teins [38–41]. Therefore, we determined the expression
levels of Nrf2 in liver, kidney, heart and lung of normal
and LPS-induced rats treated with SBH (Fig. 8). LPS
Fig. 2 LC-MS chromatogram at 280 nm of SBH
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administration significantly decreased the levels of Nrf2
in liver, kidney, heart and lung of rats when compared
with the control group. In contrast, SBH administration
significantly alleviated the levels of Nrf2 in both the liver
and kidney of LPS-induced rats. Although the 4.6 g/kg
SBH didn’t increase Nrf2 levels in the heart and lung of
LPS-induced rats, the 9.3 g/kg dose produced a signifi-
cant amelioration. Surprisingly, treatment of the normal
rats with either dose of SBH significantly increased Nrf2
levels in kidney, heart and lung and showed a trend in-
crease in the liver.
Effect of SBH on liver, kidney and heart function markers
in LPS-induced rats
The assessment of liver, kidney and heart function and
injury was determined by measuring serum levels of
ALT, AST, ALP, creatinine, urea and CK. As represented
in Fig. 9, LPS-induced rats exhibited a significant (P <
0.05) increase in serum ALT (Fig. 9A), AST (Fig. 9B),
ALP (Fig. 9C), creatinine (Fig. 9D), urea (Fig. 9E) and
CK (Fig. 9E) when compared with the control rats.
Treatment of the LPS-induced rats with SBH signifi-
cantly ameliorated serum levels of the liver, kidney and
heart function markers. In contrast, oral supplementa-
tion of SBH didn’t alter these markers in serum of nor-
mal rats.
Effect of SBH on LPS-induced histopathological changes
in rats
Microscopic examination of the H&E-stained sections in
the liver of control and SBH-supplemented rats showed
normal structure of the hepatic lobules, hepatocytes and
sinusoids (Fig. 10). In contrast, LPS-induced rats exhib-
ited several histopathological changes, including infiltra-
tion of lymphocytes and neutrophils, necrosis and other
manifestations (Fig. 10), as well as, significantly in-
creased inflammation score when compared with the
control rats (Fig. 11). Oral supplementation of SBH re-
sulted in attenuation of the inflammatory cell infiltration
(Fig. 10) and significantly reduced inflammation score
when compared with the LPS control group (Fig. 11).
H&E-stained sections in the kidney of LPS-induced
rats showed significant degenerative changes, including
degeneration of tubular cells, modest glomerular atro-
phy, granuloma, blood cells extravasating into the tubu-
lointerstitial spaces and aggregation of inflammatory
cells (Fig. 10). In addition, LPS-induced rats exhibited
significantly increased inflammation score in the kidney
when compared with the control group (Fig. 11). The
kidney of LPS-induced rats treated with SBH showed a
significant attenuation in inflammatory cells infiltration
(Fig. 10) and inflammation score (Fig. 11).
Microscopic examination of the H&E-stained sections
in the heart revealed significant changes during the
Fig. 3 Effect of SBH on (a) body weight changes, (b) food intake and (c)
survival rate in control and LPS-induced rats. Data are mean ± standard
error of the mean (n= 6). Significantly different values are indicated by
different superscripts
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experimental period, as presented in Fig. 10. The inflam-
matory and degenerative changes in LPS-induced rats
are manifested in neutrophils and lymphocytes infiltra-
tion along with cardiomyocyte damage. These patho-
logical features were attenuated in SBH-treated
LPS-induced rats as showed by the decreased infiltration
of neutrophils and lymphocytes, and the significantly re-
duced inflammation score when compared with the LPS
control group (Fig. 11).
The histological examination of lung tissues of the
LPS-induced rats demonstrated significant infiltration of
inflammatory leukocytes into alveolar and interstitial
spaces, along with edema and tissue destruction (Fig. 10).
When compared with the control group, LPS-induced
rats showed a significant increase in inflammation score
(Fig. 11). SBH treatment reduced the inflammatory cells
infiltration and tissue damage in the lung of
LPS-induced rats (Figs. 10 & 11).
Discussion
CSSI, also known as low-grade chronic inflammation,
has been considered as the major link in the pathogen-
esis of several noncommunicable diseases, including type
2 diabetes, obesity, metabolic syndrome, osteopenia, and
neurodegenerative and cardiovascular diseases [8, 10, 11,
13]. Herein, a model of LPS-induced male rats was
appointed successfully to investigate, for the first time,
the impact of SBH supplementation on CSSI. Oral sup-
plementation of SBH remarkably improved body weight,
food intake and the survival rate of LPS-induced rats. In
addition, SBH ameliorated LPS-induced leukocytosis, neu-
trophilia, lymphocytosis and monocytosis, indicating its
Fig. 4 SBH ameliorates LPS-induced (a) leukocytosis, (b) neutrophilia, (c) lymphocytosis, (d) monocytosis and (e) neutrophils/lymphocytes ratio in
rats. Data are mean ± standard error of the mean (n = 6). Significantly different values are indicated by different superscripts
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potent anti-inflammatory efficacy. In support of these
findings, SBH decreased the circulating levels of CRP,
TNF-α, IL-1β, IL-6, IL-8 and MCP-1, and diminished
NF-κB and p38 MAPK signaling in different tissues of
LPS-induced rats. Simultaneously, SBH enhanced antioxi-
dant defenses, up-regulated Nrf2, and attenuated lipid per-
oxidation and oxidative DNA damage in LPS-induced
rats. Therefore, SBH prevented LPS-induced CSSI via its
dual ability to attenuate inflammation and oxidative stress.
LPS has been widely used both in vitro and in vivo to
evaluate the anti-inflammatory potential of many agents
[42], and long-term administration of LPS can mimic
chronic inflammation diseases [43]. In addition, explor-
ing the low-dose influx of LPS to illustrate the etiology
of chronic inflammatory conditions has been justified by
the plentiful presence of LPS in the surrounding [8].
Therefore, many experimental studies have used LPS to
induce chronic subclinical inflammation either by inter-
mittent injection or by using osmotic pump release [44,
45]. In line with these reports, the current study demon-
strated that the selected dose and administration fre-
quency of LPS have successfully produced the typical
features of CSSI, including partial suppression of food
intake and body weight gain, leukocytosis and elevated
pro-inflammatory mediators in the peripheral circula-
tion. The daily consumption of SBH ameliorated the im-
pact of CSSI on animal performance through improving
food intake and maintaining a normal body weight gain.
Consuming functional foods rich in bioactive com-
pounds such as polyphenols has been well-documented
to preserve hemostasis during low-grade chronic inflam-
mation [46]. In addition, the long-term consumption of
Fig. 5 SBH attenuates LPS-induced inflammation in rats. Treatment with 4.6 and 9.3 g/kg SBH for 30 days significantly reduced serum levels of
(a) CRP, (b) TNF-α, (c) IL-1β, (d) IL-6, (e) IL-8 and (f) MCP-1 in LPS-induced rats. Data are mean ± standard error of the mean (n = 6).
Significantly different values are indicated by different superscripts
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SBH has been proven previously to maintain normal
food intake and body weight gain [47].
CSSI is associated with activation of NF-κB and p38
MAPK which represent the key signaling pathways in-
volved in regulating inflammation. NF-κB is a
redox-sensitive transcription factor that is activated by
ROS, leading to increased production of inflammatory
cytokines, including IL-1β, IL-6, TNF-α and others. In
addition, ROS have been implicated in the activation of
p38 MAPK [48], a kinase that regulates the production
of IL-1β and TNF-α [49]. Hence, attenuation of NF-κB
and p38 MAPK signaling can suppress the production of
pro-inflammatory cytokines. Interestingly, our results
demonstrated that oral supplementation of SBH
down-regulated both NF-κB and p38 MAPK in the liver,
kidney, heart and lung, and ameliorated leukocytosis and
serum inflammatory mediators in LPS-induced rats.
These results are consistent with recent studies showing
the anti-inflammatory activities of honey and its constit-
uents [50–54]. Accordingly, propolis, a resinous mixture
of bee saliva and beeswax, has down-regulated NF-κB
and p38 MAPK in LPS-stimulated Raw 246.7 cells. The
effect of propolis was attributed to the presence of
hydroxycinnamic acids [51]. It is worth mentioning that
hydroxycinnamic acids, including caffeic and coumaric
acids have been identified in SBH [22] and have shown
to alleviate inflammation through modulating NF-κB
and p38 MAPK pathways [51]. Caffeic acid phenethyl
ester, the principal component of propolis, has been re-
cently reported to suppress inflammation in the brain of
hexavalent chromium-induced rats [55]. In addition,
supplementation of Gelam honey improved the survival
of animals and improved antioxidants after 24 h of LPS
administration [50].
Leukocytosis has been considered as an indicator of
CSSI [56], and other chronic diseases, such as, type 2
diabetes, cardiovascular and neurodegenerative diseases
and metabolic syndrome [57–60]. Here, frequent LPS
administration increased WBCs number which could be
attributed to increased production of leukocytes from
bone marrow [61]. The plentiful presence of macro-
phages and lymphocytes during CSSI is due to the on-
going stimulation and the increased production of
chemokines and chemoattractant factors by immune
cells and capillary endothelium which subsequently fa-
cilitate immune cell infiltration into the tissues [62]. In
this context, microscopic examination of the liver, kid-
ney, heart and lung tissues of LPS-induced rats revealed
a significant infiltration of inflammatory leukocytes.
Additionally, increased neutrophil-lymphocyte ratio
(NLR) has been considered as a prognostic tool for CSSI
and a predictor of survival in different chronic condi-
tions [63]. In contrast, it has been documented that
diet rich in polyphenols and/or fish oil normalized
the absolute WBCs count and NLR through reducing
the release of chemoattractant factors [64]. In our
study, LC-ESI-MS/MS analysis showed the rich poly-
phenol content of SBH and this can explain, at least
in part, the ameliorative potential of SBH on
LPS-induced leukocytosis, inflammation and tissue
damage. In addition to amelioration of leukocytosis,
SBH reduced the circulating levels of inflammatory
mediators, including CRP, MCP-1, TNF-α, IL-1β and
IL-6 in LPS-induced rats.
Fig. 6 SBH suppresses (a) NF-κB p65 and (b) p38 MAPK in liver, kidney, heart and lung of LPS-induced rats. Data are mean ± standard error of the
mean (n = 6). Significantly different values are indicated by different superscripts
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Elevated serum levels of CRP are associated with
different chronic inflammatory diseases, including cor-
onary heart disease, rheumatoid arthritis and cancer
[65]. CRP is released by hepatocytes in response to
pro-inflammatory cytokines and functions to activate the
classical complement pathway which in turn prevent
autoimmunity and defend against infection [66]. CSSI
has been reported to be associated with elevated levels
of CRP [15]. SBH supplementation remarkably amelio-
rated serum CRP levels in LPS-induced rats which could
be a direct result of its high content of phenolic com-
pounds and flavonoids [22]. The dietary intake of flavo-
noids has been inversely associated with CRP levels
among adults [67], and supplementation of honey for 12
weeks was reported to normalize CRP in chronic
smokers [53]. Similarly, the dietary intake of honey for
15 days by diabetic and hyperlipidemic subjects was as-
sociated with lower levels of CRP [68]. Furthermore,
MCP-1 plays a key role in developing CSSI via increas-
ing the recruitment of bone-derived monocytes, stimu-
lating macrophage cell division and enhancing
macrophage infiltration into tissues [69]. Therefore,
amelioration of MCP-1 levels by SBH might have a sig-
nificant role in the suppressed infiltration of leukocytes
into the liver, kidney, heart and lung of LPS-induced rats
in the present investigation.
Given the role of ROS in the activation of NF-κB and
p38 MAPK and the subsequent release of
pro-inflammatory cytokines, oxidative stress is impli-
cated in the pathophysiological changes during CSSI.
Accordingly, LPS-induced rats showed a significant in-
crease in lipid peroxidation and oxidative DNA damage,
Fig. 7 SBH attenuates LPS-induced (a) lipid peroxidation and (b) oxidative DNA damage, and enhances the antioxidants (c) GSH, (d) GPx and (e)
GST in control and LPS-induced rats. Data are mean ± standard error of the mean (n = 6). Significantly different values are indicated by
different superscripts
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Fig. 8 SBH up-regulates Nrf2 in the liver, kidney, heart and lung of normal and LPS-induced rats. Data are mean ± standard error of the
mean (n = 6). Significantly different values are indicated by different superscripts
Fig. 9 SBH alleviates serum levels of (a) ALT, (b) AST, (c) ALP, (d) creatinine, (e) urea and (f) CK in LPS-induced rats. Data are mean ± standard
error of the mean (n = 6). Significantly different values are indicated by different superscripts
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accompanied with diminished antioxidant defenses. In
addition, the redox-sensitive Nrf2 was significantly
down-regulated in the liver, kidney, heart and lung of
LPS-induced rats, demonstrating excessive production
of ROS and oxidative stress. Nrf2 is a transcription
factor that regulates the gene expression of endogen-
ous phase II detoxifying and antioxidant enzymes.
Nrf2 has been thought to be a therapeutic target for
ameliorating chronic low-grade inflammation [70, 71].
Recent studies have shown that Nrf2 activation is as-
sociated with attenuation of oxidative stress and en-
hancement of antioxidant defenses in liver, kidney,
brain and endothelial cells [72–79]. Interestingly, SBH
treatment increased the protein levels of Nrf2 in liver,
kidney, heart and lung of the LPS-induced rats. Con-
sequently, LPS-induced rats treated with SBH exhib-
ited reduced lipid peroxidation and oxidative DNA
damage, and enhanced antioxidant defenses. More
interestingly, SBH up-regulated Nrf2 in normal rats.
Hence, it is suggested that the regular supplementa-
tion of SBH promotes the endogenous antioxidant
system. In addition, the anti-inflammatory effect of
SBH could be connected to its ability to up-regulate
Nrf2. In this context, the lack of Nrf2 in mouse
primary astrocytes augmented the production of
inflammatory cytokines [80]. Furthermore, these
pharmacological actions were further confirmed in
the histological sections of liver, kidney, heart and
Fig. 10 SBH attenuates histological alterations in the liver, kidney, heart and lung of LPS-induced rats. Microscopic examination of H&E-stained
sections of the control and 9.3 g/kg SBH-supplemented rats revealed normal histological structure of the liver, kidney, heart and lung. In contrast,
liver sections of the LPS-induced rats showed an increase in lymphocytes (arrow heads) and neutrophils (arrows) infiltration and necrosis (circle).
LPS-induced rats received 4.6 or 9.3 g/kg SBH showed a significant reduction in lymphocyte (arrow heads) and neutrophils (arrows) infiltration
and improved liver histology. The kidney of LPS-induced rats showed infiltration of lymphocytes (arrow heads) and neutrophils (arrows), renal
granuloma (circle) and degeneration of tubular cells. SBH-supplemented LPS-induced rats showed significantly reduced infiltration of lymphocytes
(arrow heads) and neutrophils (arrows). The heart sections of LPS-induced rats showed degeneration of cardiomyocytes and infiltration of
lymphocytes (arrow heads) and neutrophils (arrows), and the lung sections revealed edema, alveolar wall thickness and lymphocytes (arrow
heads) and neutrophils (arrows) infiltration. Treatment of the LPS-induced rats with 4.6 or 9.3 g/kg SBH resulted in reduced infiltration of
lymphocytes (arrow heads) and neutrophils (arrows) and improved histological appearance of the heart and lung tissues
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Fig. 11 Inflammation score of the liver, kidney, heart and lung of SBH-supplemented control and LPS-induced rats. Data are mean ± standard
error of the mean (n = 6). Significantly different values are indicated by different superscripts
Fig. 12 The proposed mechanism underlying the ameliorative effect of SBH on LPS-induced CSSI induced. The binding of LPS with Toll-like
receptor 4 (TLR-4) provokes the production of reactive oxygen species (ROS) in the mitochondria, and activates p38 mitogen activated protein
kinase (p38 MAPK) and nuclear factor-kappaB (NF-κB), resulting in the production of inflammatory cytokines and tissue damage. SBH up-regulates
nuclear factor (erythroid-derived 2)-like 2 (Nrf2), enhances antioxidant defenses, attenuates ROS production, and suppresses NF-κB and p38 MAPK
signaling, leading to diminished inflammation. Therefore, SBH prevented LPS-induced CSSI via its dual ability to attenuate inflammation and
oxidative stress
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lung where SBH attenuated the infiltration of inflam-
matory leukocytes and prevented tissue damage.
Limitations in nutritional biochemistry research are
unavoidable matters due to several challenges, such as,
limited time, confounding factors and the high cost of
arrays. One of the limitations in the current study is the
seasonal collection and floral type of SBH which in turn
can affect its phenolic profile and subsequently the
pharmacological actions. Another limitation in this re-
search is that anti-inflammatory mediators and adhesion
molecules were not measured.
Conclusions
The results reported in this investigation demonstrated
that SBH supplementation conferred protection against
CSSI through attenuating oxidative stress and inflamma-
tion. The anti-inflammatory and antioxidant efficacies of
SBH are mediated via up-regulation of Nrf2 and sup-
pression of NF-κB and p38 MAPK signaling (a mechan-
istic pathway is represented in Fig. 12). These findings
indicate that SBH could be a potential candidate for
ameliorating and preventing CSSI and related chronic
diseases.
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